nyseamerican:sens
|
155121
|
Apr 13th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
151.00
|
Open
|
|
Apr 13th, 2024 06:53AM
|
Apr 13th, 2024 06:54PM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 12th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
151.00
|
Open
|
|
Apr 12th, 2024 07:09AM
|
Apr 12th, 2024 04:08PM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 11th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
149.00
|
Open
|
|
Apr 11th, 2024 09:13AM
|
Apr 11th, 2024 07:10PM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 10th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 10th, 2024 06:55AM
|
Apr 11th, 2024 04:05AM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 9th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 9th, 2024 07:17AM
|
Apr 9th, 2024 05:26PM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 8th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 8th, 2024 07:50AM
|
Apr 8th, 2024 07:50AM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 7th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 7th, 2024 07:23AM
|
Apr 7th, 2024 07:23AM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 6th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 6th, 2024 07:04AM
|
Apr 6th, 2024 07:04AM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 5th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 5th, 2024 09:45AM
|
Apr 5th, 2024 09:45AM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|
nyseamerican:sens
|
155121
|
Apr 4th, 2024 12:00AM
|
Senseonics, Incorporated
|
11K
|
148.00
|
Open
|
|
Apr 4th, 2024 07:31AM
|
Apr 4th, 2024 04:59PM
|
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
|
Open
|
diabetes, glucose sensor, continuous glucose monitor, and active implantable medical device
|
Open
|
20451 Seneca Meadows Pkwy
|
Germantown
|
Maryland
|
US
|
20876
|
|
Senseonics
|
|
|